Anti-CD33 antibodies and methods of use thereof

US12247073B2 · kind B2 · utility

Assignee

• Alector LLC

Inventors

• Patricia Culp · Oakland, US
• Helen LAM · Union City, US
• Wei-Hsien Ho · Belmont, US
• Leonard G. Presta · San Francisco, US
• Arnon Rosenthal · Woodside, US

Key dates

• Filing date: Aug 30, 2019
• Grant date: Mar 11, 2025
• Expiry date: Jul 11, 2042

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a CD33 polypeptide, e.g., a mammalian CD33 or human CD33, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.